[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

IMGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.07%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $35,723,707.24

ImmunoGen Insider Trading History Chart

ImmunoGen Share Price & Price History

^$16.06

▲ +0.08 (0.50%)

As of 11/29/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

ImmunoGen Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/17/2023	Stacy Ann Coen	SVP	Sell	78,223	$16.05	$1,255,479.15	36,966
11/15/2023	Theresa Wingrove	SVP	Sell	166,725	$15.85	$2,642,591.25	2,811
11/7/2023	Theresa Wingrove	SVP	Sell	19,517	$16.66	$325,153.22	2,811
11/6/2023	Renee Lentini	VP	Sell	219,545	$15.29	$3,356,843.05
10/16/2023	Theresa Wingrove	SVP	Sell	192,004	$14.40	$2,764,857.60	2,811
9/15/2023	Theresa Wingrove	SVP	Sell	192,013	$15.44	$2,964,680.72	2,811
8/9/2023	Stacy Ann Coen	SVP	Sell	100,210	$14.20	$1,422,982.00	10,960
8/4/2023	Stacy Ann Coen	SVP	Sell	80,326	$17.05	$1,369,558.30	10,960
8/3/2023	Mark J. Enyedy	CEO	Sell	1,020,000	$16.61	$16,942,200.00	441,449
8/2/2023	Renee Lentini	Insider	Sell	148,277	$17.55	$2,602,261.35	22,843
8/2/2023	Stacy Ann Coen	SVP	Sell	4,255	$18.12	$77,100.60	10,960
12/31/2020	David G Foster	VP	Sell	11,052	$6.38	$70,511.76

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for ImmunoGen (NASDAQ:IMGN)

90.50% of ImmunoGen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ImmunoGen Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/29/2023	Decheng Capital Management III Cayman LLC	415,880	$6.60M	1.7%	N/A	0.156%
11/24/2023	Deutsche Bank AG	225,066	$3.57M	0.0%	-93.2%	0.085%
11/22/2023	Graham Capital Management L.P.	35,572	$0.57M	0.0%	N/A	0.013%
11/21/2023	Comerica Bank	25,379	$0.40M	0.0%	N/A	0.010%
11/17/2023	Diversified Trust Co	42,517	$0.68M	0.0%	+4.4%	0.016%
11/16/2023	Creative Planning	20,000	$0.32M	0.0%	+18.9%	0.008%
11/16/2023	Ironwood Investment Management LLC	174,646	$2.77M	1.7%	-10.0%	0.066%
11/16/2023	GTS Securities LLC	12,199	$0.19M	0.0%	N/A	0.005%
11/16/2023	Morgan Stanley	4,829,091	$76.64M	0.0%	+44.6%	1.814%
11/15/2023	The Manufacturers Life Insurance Company	229,618	$3.64M	0.0%	+42.0%	0.086%
11/15/2023	RA Capital Management L.P.	13,322,288	$211.43M	4.2%	+471.8%	5.003%
11/15/2023	GSA Capital Partners LLP	114,155	$1.81M	0.2%	+222.8%	0.043%
11/15/2023	Royal Bank of Canada	43,341	$0.69M	0.0%	+98.0%	0.016%
11/15/2023	Redmile Group LLC	17,503,417	$277.78M	13.2%	-1.3%	6.574%
11/15/2023	Rock Springs Capital Management LP	759,365	$12.05M	0.3%	+574.3%	0.285%
11/15/2023	Scotia Capital Inc.	14,979	$0.24M	0.0%	+13.4%	0.006%
11/15/2023	Sectoral Asset Management Inc.	464,112	$7.37M	1.4%	+6.3%	0.174%
11/15/2023	Sei Investments Co.	193,702	$3.07M	0.0%	+0.7%	0.073%
11/15/2023	Seven Eight Capital LP	238,930	$3.79M	0.4%	+146.4%	0.090%
11/15/2023	Legal & General Group Plc	214,575	$3.41M	0.0%	+1.0%	0.081%
11/15/2023	Adage Capital Partners GP L.L.C.	200,000	$3.17M	0.0%	-69.2%	0.075%
11/15/2023	AXQ Capital LP	13,000	$0.21M	0.1%	N/A	0.005%
11/15/2023	Glenmede Trust Co. NA	34,813	$0.55M	0.0%	N/A	0.013%
11/15/2023	AQR Capital Management LLC	125,637	$1.99M	0.0%	+384.9%	0.047%
11/14/2023	Lazard Asset Management LLC	19,406	$0.31M	0.0%	N/A	0.007%
11/14/2023	Schonfeld Strategic Advisors LLC	392,500	$6.23M	0.0%	+4.1%	0.147%
11/14/2023	Gotham Asset Management LLC	12,278	$0.20M	0.0%	-29.9%	0.005%
11/14/2023	Corton Capital Inc.	29,506	$0.47M	0.2%	N/A	0.011%
11/14/2023	Fred Alger Management LLC	354,859	$5.63M	0.0%	+817.9%	0.133%
11/14/2023	Caxton Associates LP	18,839	$0.30M	0.0%	N/A	0.007%
11/14/2023	Avidity Partners Management LP	1,917,907	$30.44M	1.2%	-4.0%	0.720%
11/14/2023	California State Teachers Retirement System	246,379	$3.91M	0.0%	-9.8%	0.093%
11/14/2023	Tower Research Capital LLC TRC	5,254	$83K	0.0%	-52.3%	0.002%
11/14/2023	Trexquant Investment LP	200,746	$3.19M	0.1%	+159.5%	0.075%
11/14/2023	Monashee Investment Management LLC	40,000	$0.64M	0.3%	N/A	0.015%
11/14/2023	OMERS ADMINISTRATION Corp	26,400	$0.42M	0.0%	N/A	0.010%
11/14/2023	Profund Advisors LLC	98,164	$1.56M	0.1%	+51.7%	0.037%
11/13/2023	Natixis Advisors L.P.	41,854	$0.66M	0.0%	-20.4%	0.016%
11/13/2023	Jacobi Capital Management LLC	16,500	$0.26M	0.0%	-37.7%	0.006%
11/13/2023	Algert Global LLC	180,317	$2.86M	0.1%	N/A	0.068%
11/13/2023	Northern Trust Corp	2,370,864	$37.63M	0.0%	-1.1%	0.890%
11/13/2023	EAM Investors LLC	155,429	$2.47M	0.5%	-19.3%	0.058%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	300,000	$4.76M	0.0%	N/A	0.113%
11/13/2023	ClariVest Asset Management LLC	54,391	$0.86M	0.0%	+77.0%	0.020%
11/13/2023	Invesco Ltd.	1,086,168	$17.24M	0.0%	+4.9%	0.408%
11/13/2023	FMR LLC	5,788,555	$91.86M	0.0%	+3.1%	2.174%
11/13/2023	Envestnet Asset Management Inc.	64,472	$1.02M	0.0%	+125.3%	0.024%
11/13/2023	Rhenman & Partners Asset Management AB	700,000	$11.11M	1.2%	-6.7%	0.263%
11/13/2023	Rafferty Asset Management LLC	566,985	$9M	0.1%	+68.1%	0.213%
11/13/2023	Lord Abbett & CO. LLC	759,450	$12.05M	0.0%	-17.4%	0.285%
11/13/2023	E Fund Management Co. Ltd.	29,125	$0.46M	0.0%	+60.6%	0.011%
11/9/2023	Rhenman & Partners Asset Management AB	178,284	$2.83M	0.2%	-76.2%	0.067%
11/9/2023	Deutsche Bank AG	225,066	$3.57M	0.0%	-93.2%	0.085%
11/9/2023	Essex Investment Management Co. LLC	7,443	$0.12M	0.0%	N/A	0.003%
11/9/2023	Citigroup Inc.	245,551	$3.90M	0.0%	+26.1%	0.092%
11/9/2023	Skandinaviska Enskilda Banken AB publ	48,515	$0.77M	0.0%	N/A	0.018%
11/9/2023	Blair William & Co. IL	254,320	$4.04M	0.0%	-0.7%	0.096%
11/9/2023	Artisan Partners Limited Partnership	3,724,583	$59.11M	0.1%	0.0%	1.399%
11/8/2023	State of New Jersey Common Pension Fund D	156,835	$2.49M	0.0%	-10.7%	0.063%
11/8/2023	Charles Schwab Investment Management Inc.	1,830,575	$29.05M	0.0%	+1.1%	0.735%
11/8/2023	Swiss National Bank	480,800	$7.63M	0.0%	+1.0%	0.193%
11/8/2023	Amalgamated Bank	31,076	$0.49M	0.0%	+2.1%	0.012%
11/8/2023	Moody Aldrich Partners LLC	283,950	$4.51M	0.9%	+38.6%	0.114%
11/7/2023	Virtus ETF Advisers LLC	17,174	$0.27M	0.2%	-11.4%	0.007%
11/7/2023	Quantbot Technologies LP	7,187	$0.11M	0.0%	-35.5%	0.003%
11/7/2023	Alpha DNA Investment Management LLC	35,896	$0.57M	0.2%	N/A	0.014%
11/7/2023	New York State Common Retirement Fund	324,926	$5.16M	0.0%	+14.3%	0.131%
11/7/2023	Barclays PLC	342,727	$5.44M	0.0%	+28.6%	0.138%
11/7/2023	Jump Financial LLC	113,128	$1.80M	0.1%	-56.1%	0.045%
11/7/2023	Arizona State Retirement System	62,272	$0.99M	0.0%	+1.4%	0.025%
11/6/2023	Los Angeles Capital Management LLC	46,985	$0.75M	0.0%	+3.8%	0.019%
11/6/2023	Victory Capital Management Inc.	140,846	$2.24M	0.0%	+16.0%	0.057%
11/6/2023	Mesirow Financial Investment Management Inc.	17,094	$0.27M	1.2%	N/A	0.007%
11/2/2023	Principal Financial Group Inc.	984,664	$15.63M	0.0%	-0.3%	0.396%
11/2/2023	Perkins Capital Management Inc.	12,100	$0.19M	0.2%	-29.7%	0.005%
11/1/2023	Orion Portfolio Solutions LLC	13,571	$0.22M	0.0%	+26.0%	0.005%
10/31/2023	Teacher Retirement System of Texas	62,140	$0.99M	0.0%	+4.7%	0.025%
10/31/2023	Panagora Asset Management Inc.	1,098,417	$17.43M	0.1%	-1.7%	0.441%
10/31/2023	China Universal Asset Management Co. Ltd.	6,385	$0.10M	0.0%	+90.3%	0.003%
10/27/2023	Hennion & Walsh Asset Management Inc.	523,074	$8.30M	0.5%	+1.5%	0.210%
10/27/2023	Allspring Global Investments Holdings LLC	12,927	$0.21M	0.0%	+74.2%	0.005%
10/27/2023	TD Asset Management Inc	282,400	$4.48M	0.0%	+188.5%	0.113%
10/27/2023	Emerald Mutual Fund Advisers Trust	1,466,063	$23.27M	1.4%	+79.4%	0.589%
10/26/2023	Emerald Advisers LLC	1,811,306	$28.75M	1.4%	+84.1%	0.728%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	134,139	$2.13M	0.0%	+9.8%	0.054%
10/26/2023	Strs Ohio	29,000	$0.46M	0.0%	-62.1%	0.012%
10/25/2023	BluePath Capital Management LLC	2,193	$35K	0.0%	N/A	0.001%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	44,709	$0.71M	0.0%	+19.0%	0.018%
10/24/2023	Bank of New York Mellon Corp	1,796,110	$28.50M	0.0%	+64.3%	0.722%
10/24/2023	Raymond James Financial Services Advisors Inc.	31,080	$0.49M	0.0%	-4.8%	0.012%
10/24/2023	Raymond James & Associates	167,578	$2.66M	0.0%	+890.1%	0.067%
10/24/2023	Pinnacle Associates Ltd.	1,016,156	$16.13M	0.3%	-16.0%	0.408%
10/24/2023	Cambridge Investment Research Advisors Inc.	21,362	$0.34M	0.0%	-8.8%	0.009%
10/23/2023	Commonwealth Equity Services LLC	25,877	$0.41M	0.0%	-5.5%	0.010%
10/19/2023	Handelsbanken Fonder AB	44,100	$0.70M	0.0%	+26.0%	0.018%
10/18/2023	Exchange Traded Concepts LLC	6,657	$0.11M	0.0%	-16.2%	0.003%
10/17/2023	Mach 1 Financial Group LLC	31,780	$0.50M	0.2%	N/A	0.013%
10/13/2023	SG Americas Securities LLC	88,215	$1.40M	0.0%	+116.5%	0.035%
10/12/2023	Legato Capital Management LLC	43,144	$0.69M	0.1%	+54.2%	0.017%
10/11/2023	Kercheville Advisors LLC	116,577	$1.85M	1.2%	-33.8%	0.047%

Data available starting January 2016

ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian cancer; and a cell-surface protein expressed in various epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers, as well as Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti-FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $16.06

$15.88

$16.69

50 Day Range

MA: $15.13

$12.46

$16.29

52 Week Range

Now: $16.06

$3.61

$20.69

Volume

4,622,960 shs

Average Volume

5,268,847 shs

Market Capitalization

$4.28 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.83

Who are the company insiders with the largest holdings of ImmunoGen?: ImmunoGen's top insider shareholders include:
Mark J Enyedy (CEO)
Stacy Ann Coen (SVP)
Renee Lentini (Insider)
Theresa Wingrove (SVP)
Renee Lentini (VP)
Learn More about top insider investors at ImmunoGen.
Who are the major institutional investors of ImmunoGen?: ImmunoGen's top institutional investors include:
Redmile Group LLC — 6.57%
RA Capital Management L.P. — 5.00%
FMR LLC — 2.17%
Morgan Stanley — 1.81%
Artisan Partners Limited Partnership — 1.40%
Northern Trust Corp — 0.89%
Learn More about top institutional investors of ImmunoGen stock.
Which institutional investors are selling ImmunoGen stock?: In the last quarter, IMGN stock was sold by these institutional investors:
Deutsche Bank AG
Deutsche Bank AG
Rhenman & Partners Asset Management AB
Adage Capital Partners GP L.L.C.
Redmile Group LLC
Pinnacle Associates Ltd.
Lord Abbett & CO. LLC
Jump Financial LLC
During the previous year, company insiders that have sold ImmunoGen company stock include:
Mark J Enyedy (CEO)
Stacy Ann Coen (SVP)
Renee Lentini (Insider)
Theresa Wingrove (SVP)
Renee Lentini (VP)
Learn More investors selling ImmunoGen stock.
Which institutional investors are buying ImmunoGen stock?: In the last quarter, IMGN stock was purchased by institutional investors including:
RA Capital Management L.P.
Morgan Stanley
Emerald Advisers LLC
Bank of New York Mellon Corp
Emerald Mutual Fund Advisers Trust
Rock Springs Capital Management LP
Decheng Capital Management III Cayman LLC
Fred Alger Management LLC

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

IMGN Insider Trading

ImmunoGen Insider Trading History Chart

ImmunoGen Share Price & Price History

ImmunoGen Insider Trading History

SEC Filings (Institutional Ownership Changes) for ImmunoGen (NASDAQ:IMGN)

Institutional Buying and Selling by Quarter

ImmunoGen Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of ImmunoGen?

Who are the major institutional investors of ImmunoGen?

Which institutional investors are selling ImmunoGen stock?

Which institutional investors are buying ImmunoGen stock?